D

DSM-Firmenich AG
AEX:DSFIR

Watchlist Manager
DSM-Firmenich AG
AEX:DSFIR
Watchlist
Price: 107.25 EUR 2.29% Market Closed
Market Cap: 28.5B EUR
Have any thoughts about
DSM-Firmenich AG?
Write Note

DSM-Firmenich AG
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

DSM-Firmenich AG
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
D
DSM-Firmenich AG
AEX:DSFIR
Total Equity
€22.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sika AG
F:SIKA
Total Equity
CHf5.9B
CAGR 3-Years
22%
CAGR 5-Years
29%
CAGR 10-Years
11%
C
Clariant AG
SIX:CLN
Total Equity
CHf2.2B
CAGR 3-Years
-1%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Givaudan SA
SIX:GIVN
Total Equity
CHf4.3B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
3%
Ems Chemie Holding AG
SIX:EMSN
Total Equity
CHf2B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
4%
Dottikon Es Holding AG
SIX:DESN
Total Equity
CHf885.8m
CAGR 3-Years
11%
CAGR 5-Years
19%
CAGR 10-Years
12%
No Stocks Found

DSM-Firmenich AG
Glance View

Market Cap
28.5B EUR
Industry
Chemicals

DSM-Firmenich AG is a global leader in the nutrition, health, and beauty sectors, born from the merger of Dutch multinational DSM and Swiss flavor and fragrance company Firmenich. This innovative company specializes in creating sustainable solutions, leveraging science and technology to enhance the quality of life across a diverse range of industries, including food, beverages, personal care, and pharmaceuticals. With a robust portfolio of products aimed at enriching human and environmental health, DSM-Firmenich aims to meet the growing consumer demand for healthier, more sustainable options. Their commitment to sustainability positions them favorably within the markets they serve, as consumers increasingly seek brands that prioritize their health and the planet. For investors, DSM-Firmenich stands out not just for its impressive offerings but also for its strategic vision that emphasizes long-term growth and resilience. The company's strong financial track record, combined with its focus on innovation and operational efficiency, underpins its potential to capitalize on emerging trends within the wellness and sustainability industries. As global populations expand and consumer preferences shift towards health-conscious choices, DSM-Firmenich is well-placed to leverage its expertise and comprehensive understanding of the market. By investing in this forward-thinking enterprise, investors can participate in a company that is not only poised for financial success but also dedicated to making a positive impact on society and the environment.

DSFIR Intrinsic Value
103.75 EUR
Overvaluation 3%
Intrinsic Value
Price
D

See Also

What is DSM-Firmenich AG's Total Equity?
Total Equity
22.9B EUR

Based on the financial report for Dec 31, 2023, DSM-Firmenich AG's Total Equity amounts to 22.9B EUR.

What is DSM-Firmenich AG's Total Equity growth rate?
Total Equity CAGR 1Y
113%

Over the last year, the Total Equity growth was 113%.

Back to Top